Cargando…

Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement

INTRODUCTION: Previous analyses have reported the outcomes of transcatheter aortic valve replacement (TAVR) for patients with low-flow, low-gradient (LFLG) aortic stenosis (AS), without stratifying according to the route of access. Differences in mortality rates among access routes have been establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maier, Julian, Lambert, Thomas, Senoner, Thomas, Dobner, Stephan, Hoppe, Uta Caroline, Fellner, Alexander, Pfeifer, Bernhard Erich, Feuchtner, Gudrun Maria, Friedrich, Guy, Semsroth, Severin, Bonaros, Nikolaos, Holfeld, Johannes, Müller, Silvana, Reinthaler, Markus, Steinwender, Clemens, Barbieri, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665844/
https://www.ncbi.nlm.nih.gov/pubmed/38028449
http://dx.doi.org/10.3389/fcvm.2023.1256112
_version_ 1785138915990044672
author Maier, Julian
Lambert, Thomas
Senoner, Thomas
Dobner, Stephan
Hoppe, Uta Caroline
Fellner, Alexander
Pfeifer, Bernhard Erich
Feuchtner, Gudrun Maria
Friedrich, Guy
Semsroth, Severin
Bonaros, Nikolaos
Holfeld, Johannes
Müller, Silvana
Reinthaler, Markus
Steinwender, Clemens
Barbieri, Fabian
author_facet Maier, Julian
Lambert, Thomas
Senoner, Thomas
Dobner, Stephan
Hoppe, Uta Caroline
Fellner, Alexander
Pfeifer, Bernhard Erich
Feuchtner, Gudrun Maria
Friedrich, Guy
Semsroth, Severin
Bonaros, Nikolaos
Holfeld, Johannes
Müller, Silvana
Reinthaler, Markus
Steinwender, Clemens
Barbieri, Fabian
author_sort Maier, Julian
collection PubMed
description INTRODUCTION: Previous analyses have reported the outcomes of transcatheter aortic valve replacement (TAVR) for patients with low-flow, low-gradient (LFLG) aortic stenosis (AS), without stratifying according to the route of access. Differences in mortality rates among access routes have been established for high-gradient (HG) patients and hypothesized to be even more pronounced in LFLG AS patients. This study aims to compare the outcomes of patients with LFLG or HG AS following transfemoral (TF) or transapical (TA) TAVR. METHODS: A total of 910 patients, who underwent either TF or TA TAVR with a median follow-up of 2.22 (IQR: 1.22–4.03) years, were included in this multicenter cohort study. In total, 146 patients (16.04%) suffered from LFLG AS. The patients with HG and LFLG AS were stratified according to the route of access and compared statistically. RESULTS: The operative mortality rates of patients with HG and LFLG were found to be comparable following TF access. The operative mortality rate was significantly increased for patients who underwent TA access [odds ratio (OR): 2.91 (1.54–5.48), p = 0.001] and patients with LFLG AS [OR: 2.27 (1.13–4.56), p = 0.02], which could be corroborated in a propensity score-matched subanalysis. The observed increase in the risk of operative mortality demonstrated an additive effect [OR for TA LFLG: 5.45 (2.35–12.62), p < 0.001]. LFLG patients who underwent TA access had significantly higher operative mortality rates (17.78%) compared with TF LFLG (3.96%, p = 0.016) and TA HG patients (6.36%, p = 0.024). CONCLUSIONS: HG patients experienced a twofold increase in operative mortality rates following TA compared with TF access, while LFLG patients had a fivefold increase in operative mortality rates. TA TAVR appears suboptimal for patients with LFLG AS. Prospective studies should be conducted to evaluate alternative options in cases where TF is not possible.
format Online
Article
Text
id pubmed-10665844
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106658442023-01-01 Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement Maier, Julian Lambert, Thomas Senoner, Thomas Dobner, Stephan Hoppe, Uta Caroline Fellner, Alexander Pfeifer, Bernhard Erich Feuchtner, Gudrun Maria Friedrich, Guy Semsroth, Severin Bonaros, Nikolaos Holfeld, Johannes Müller, Silvana Reinthaler, Markus Steinwender, Clemens Barbieri, Fabian Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: Previous analyses have reported the outcomes of transcatheter aortic valve replacement (TAVR) for patients with low-flow, low-gradient (LFLG) aortic stenosis (AS), without stratifying according to the route of access. Differences in mortality rates among access routes have been established for high-gradient (HG) patients and hypothesized to be even more pronounced in LFLG AS patients. This study aims to compare the outcomes of patients with LFLG or HG AS following transfemoral (TF) or transapical (TA) TAVR. METHODS: A total of 910 patients, who underwent either TF or TA TAVR with a median follow-up of 2.22 (IQR: 1.22–4.03) years, were included in this multicenter cohort study. In total, 146 patients (16.04%) suffered from LFLG AS. The patients with HG and LFLG AS were stratified according to the route of access and compared statistically. RESULTS: The operative mortality rates of patients with HG and LFLG were found to be comparable following TF access. The operative mortality rate was significantly increased for patients who underwent TA access [odds ratio (OR): 2.91 (1.54–5.48), p = 0.001] and patients with LFLG AS [OR: 2.27 (1.13–4.56), p = 0.02], which could be corroborated in a propensity score-matched subanalysis. The observed increase in the risk of operative mortality demonstrated an additive effect [OR for TA LFLG: 5.45 (2.35–12.62), p < 0.001]. LFLG patients who underwent TA access had significantly higher operative mortality rates (17.78%) compared with TF LFLG (3.96%, p = 0.016) and TA HG patients (6.36%, p = 0.024). CONCLUSIONS: HG patients experienced a twofold increase in operative mortality rates following TA compared with TF access, while LFLG patients had a fivefold increase in operative mortality rates. TA TAVR appears suboptimal for patients with LFLG AS. Prospective studies should be conducted to evaluate alternative options in cases where TF is not possible. Frontiers Media S.A. 2023-11-09 /pmc/articles/PMC10665844/ /pubmed/38028449 http://dx.doi.org/10.3389/fcvm.2023.1256112 Text en © 2023 Maier, Lambert, Senoner, Dobner, Hoppe, Fellner, Pfeifer, Feuchtner, Friedrich, Semsroth, Bonaros, Holfeld, Müller, Reinthaler, Steinwender and Barbieri. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Maier, Julian
Lambert, Thomas
Senoner, Thomas
Dobner, Stephan
Hoppe, Uta Caroline
Fellner, Alexander
Pfeifer, Bernhard Erich
Feuchtner, Gudrun Maria
Friedrich, Guy
Semsroth, Severin
Bonaros, Nikolaos
Holfeld, Johannes
Müller, Silvana
Reinthaler, Markus
Steinwender, Clemens
Barbieri, Fabian
Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title_full Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title_fullStr Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title_full_unstemmed Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title_short Impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
title_sort impact of route of access and stenosis subtype on outcome after transcatheter aortic valve replacement
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665844/
https://www.ncbi.nlm.nih.gov/pubmed/38028449
http://dx.doi.org/10.3389/fcvm.2023.1256112
work_keys_str_mv AT maierjulian impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT lambertthomas impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT senonerthomas impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT dobnerstephan impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT hoppeutacaroline impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT fellneralexander impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT pfeiferbernharderich impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT feuchtnergudrunmaria impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT friedrichguy impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT semsrothseverin impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT bonarosnikolaos impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT holfeldjohannes impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT mullersilvana impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT reinthalermarkus impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT steinwenderclemens impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement
AT barbierifabian impactofrouteofaccessandstenosissubtypeonoutcomeaftertranscatheteraorticvalvereplacement